A novel gene 098P4B6 (also designated STEAP-2) and its encoded protein, and variants thereof, are described wherein 98P4B6 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 98P4B6 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 98P4B6 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization.

 
Web www.patentalert.com

< Ceramide derivatives as modulators of immunity and autoimmunity

< Tyrosinase activity cntrolling agent, process for producing the same and external preparations containing the same

> Partial and full agonists of A1 adenosine receptors

> 2-Substituted-6-trifluoromethyl purine derivatives with adenosine-A3 antagonistic activity
~ 00244